Stellenwert des Hevylite®-Assay in der Diagnose sowie der Rezidiv- bzw. Verlaufsbeurteilung beim Multiplen Myelom
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig3_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Multiples Myelom – Plasmozytom – Plasmazellen außer Kontrolle: Im Zentrum der Diagnostik steht das Paraprotein Multiples Myelom – Plasmozytom – Plasmazellen außer Kontrolle: Im Zentrum der Diagnostik steht das Paraprotein](https://www.trillium.de/fileadmin/user_upload/DidO_Plasmozytom_Gruber_Tab1.jpg)
Multiples Myelom – Plasmozytom – Plasmazellen außer Kontrolle: Im Zentrum der Diagnostik steht das Paraprotein
![IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | Annals of Hematology IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | Annals of Hematology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-020-04046-x/MediaObjects/277_2020_4046_Fig1_HTML.png)
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | Annals of Hematology
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig1_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-021-00406-6/MediaObjects/41408_2021_406_Fig1_HTML.png)